1. Song, Ke, Yang, Xinyan, An, Geng, Liu, Zhaoting, Zhao, Xiao-Yang. 2022. Targeting APLN/APJ restores blood-testis barrier and improves spermatogenesis in murine and human diabetic models. In Nature communications, 13, 7335. doi:10.1038/s41467-022-34990-3. https://pubmed.ncbi.nlm.nih.gov/36443325/
2. Wang, Qi, Wang, Bingyu, Zhang, Wenjing, Hao, Chunyan, Cui, Baoxia. 2024. APLN promotes the proliferation, migration, and glycolysis of cervical cancer through the PI3K/AKT/mTOR pathway. In Archives of biochemistry and biophysics, 755, 109983. doi:10.1016/j.abb.2024.109983. https://pubmed.ncbi.nlm.nih.gov/38561035/
3. Gandham, Rajeev, Dayanand, C D, Sheela, S R, Kiranmayee, P. 2021. Maternal serum Apelin 13 and APLN gene promoter variant -1860T > C in preeclampsia. In The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians, 35, 5008-5016. doi:10.1080/14767058.2021.1874341. https://pubmed.ncbi.nlm.nih.gov/33455513/
4. Creff, Justine, Lamaa, Asalaa, Benuzzi, Emeline, Prats, Anne-Catherine, Garmy-Susini, Barbara. 2024. Apelin-VEGF-C mRNA delivery as therapeutic for the treatment of secondary lymphedema. In EMBO molecular medicine, 16, 386-415. doi:10.1038/s44321-023-00017-7. https://pubmed.ncbi.nlm.nih.gov/38177539/
5. Hennigs, Jan K, Cao, Aiqin, Li, Caiyun G, Snyder, Michael P, Rabinovitch, Marlene. 2020. PPARγ-p53-Mediated Vasculoregenerative Program to Reverse Pulmonary Hypertension. In Circulation research, 128, 401-418. doi:10.1161/CIRCRESAHA.119.316339. https://pubmed.ncbi.nlm.nih.gov/33322916/
6. Chen, Huarong, Wong, Chi-Chun, Liu, Dabin, Wong, Nathalie, Yu, Jun. 2019. APLN promotes hepatocellular carcinoma through activating PI3K/Akt pathway and is a druggable target. In Theranostics, 9, 5246-5260. doi:10.7150/thno.34713. https://pubmed.ncbi.nlm.nih.gov/31410213/
智鼠故事 
